俞鸣, 郝继辉, 焦振山, 史玉荣, 郝希山, 王庆生. 卵巢上皮性癌BRCA1和p53基因表达的临床意义及相互关系研究[J]. 中国肿瘤临床, 2005, 32(1): 18-20.
引用本文: 俞鸣, 郝继辉, 焦振山, 史玉荣, 郝希山, 王庆生. 卵巢上皮性癌BRCA1和p53基因表达的临床意义及相互关系研究[J]. 中国肿瘤临床, 2005, 32(1): 18-20.
Yu Ming, Hao Jihui, Jiao Zhenshan, Shi Yurong, Hao Xishan, Wang Qingsheng. A Study on the Expression of BRCA1&P53 and Their Correlation in Epithelial Ovarian Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 32(1): 18-20.
Citation: Yu Ming, Hao Jihui, Jiao Zhenshan, Shi Yurong, Hao Xishan, Wang Qingsheng. A Study on the Expression of BRCA1&P53 and Their Correlation in Epithelial Ovarian Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 32(1): 18-20.

卵巢上皮性癌BRCA1和p53基因表达的临床意义及相互关系研究

A Study on the Expression of BRCA1&P53 and Their Correlation in Epithelial Ovarian Cancer

  • 摘要: 目的:探讨BRCA1、p53基因蛋白在卵巢上皮性癌中的表达情况及相互关系。方法:应用S-P免疫组织化学法检测50例卵巢上皮性癌组织中BRCA1和p53蛋白的表达。采用Kaplan-Meier法分析两种蛋白表达情况与患者预后的关系。结果:1)BRCA1蛋白在卵巢癌组织中的阳性表达率仅为30%,明显低于正常卵巢组织(100%)和良性肿瘤组织(90%)(P<0.01);BRCA1在低分化癌、有淋巴结转移的卵巢癌组织中表达减少甚至缺失。2)p53蛋白在卵巢癌组织中的表达率为64%,而在正常卵巢及良性肿瘤组织中无表达;其表达仅与病理学分级有关。3)两种基因蛋白表达比较呈显著负相关(P<0.01)。4)患者生存随访表明,有BRCA1表达的患者平均生存期长于无表达者;而p53对生存时间无影响。结论:BRCA1基因在转录后水平的下调对卵巢上皮性癌的发生发展有重要的作用,同时BRCA1基因与p53基因协同促进肿瘤的演进恶化。

     

    Abstract: Objective:To study the expressions of BRCA1 and p53 in epithelial ovarian cancer and their clinical significance. Methods: BRCA1 and p53 protein expressions were detected in 50 epithelial ovarian cancers.Kaplan-Meier method was used to analyze the relationship between their expressions and prognosis. Results: 1, The expression rate of BRCA1 was 30.0% in ovarian cancers,which was lower than that in benign tumor and normal ovary tissues significantly (P<0.01). And BRCA1 expression was correlated with pathological grade and pelvic lymph node metastasis.2,The expression rate of p53 was 64.0%, while the expression was negative in benign tumor and normal ovary tissues,and it related to pathological grade.3,There was negative correlation between the expressions of the two protein (P<0.01). 4, The mean survival time was longer in the patients with BRCA1 expression than those without. There was no effect of p53 on survival time. Conclusions: Down-regulation of BRCA1 gene in post-transcription plays a very important role in the occurrence and the development of ovarian cancer, and p53 gene maybe has a synergetic role with BRCA1 to promote tumor progression.

     

/

返回文章
返回